Stockhub

Medlab Clinical Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 August 2022

  • curprev 08:5708:57, 19 August 2022 >Nick 959 bytes +959 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Medlab Clinical Limited, a biotechnology company, researches, develops, and commercializes pharmaceutical and nutraceutical products in Australia. Its lead drug candidate includes NanaBis, an oro–buccal administered equimolar tetrahydrocannabinol (THC) and cannabidiol (CBD) formulation as monotherapy, which is in phase 3 multi-centre, quadruple-blind, randomized- withdrawal active, and placebo-controlled clinical study for..."
Retrieved from "https://stockhub.co/research/Medlab_Clinical_Limited"